2 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Pneumocystis Pneumonia: new trials by email Literature Review of Pneumocystis Pneumonia trials Research Report on Pneumocystis Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection | Phase 1 / Phase 2 | Recruiting | University Hospital, Tours | 100 | 2025-12-02 | 2026-10-09 |
| Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults Co-Trimoxazole, Rezafungin Acetate / Co Trimoxazole - Pneumocystis Pneumonia | Phase 2 | Recruiting | Mundipharma Research Limited | 50 | 2023-11-14 | 2025-04-03 |
Pneumonia, Pneumocystis (2) · Lung Diseases, Interstitial (1) · Pneumocystis Infections (1) · Respiratory Aspiration (1)
Bacterial Infections and Mycoses (2) · Infections (2) · Lung Diseases (2) · Lung Diseases, Fungal (2) · Mycoses (2) · Pneumonia (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumocystis Infections (1) · Respiration Disorders (1)
Caspofungin (1) · Rezafungin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Mundipharma Research Limited (1) · University Hospital, Tours (1)
France (1) · South Africa (1)
Mohit Joshi, MD (1)
PMID 41151592, PMID 16304338, PMID 18046534, PMID 20946413, PMID 22548840, PMID 23940606, PMID 26935726, PMID 30776290, PMID 31548210, PMID 31633150, PMID 32194238, PMID 9872631
2023 (1)